Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue SUPPL. 1, 2007, Pages 104-106

  Vergara, Pasquale ^a,c   Picardi, Giuseppe ^b   Nigro, Gerardo ^a   Scaturo, Francesco ^b   de Chiara, Annabella ^a   Calabrò, Raffaele ^a   Vergara, Giuseppe ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Nola Hospital   (Italy)

^c NONE   (Italy)

Author keywords

Arrhythmias; Atrial fibrillation; Hyperthyroidism; Hypothyroidism; Thyroid dysfunction

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART ATRIUM FIBRILLATION; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX DIFFERENCE; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; HYPERTHYROIDISM; ITALY; MALE; MIDDLE AGED; PREVALENCE; SEX FACTORS; THYROID HORMONES;

EID: 34447106339     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.
3. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 459-73.
4. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study). Am J Cardiol 1994; 74: 235-41.
5. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359-64.
6. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987; 1: 526-9.
7. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-8.
8. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 1999; 99: 3028-35.
9. Darbar D, Herron KJ, Ballew JD, Jahangir A, Gersh BJ, Shen WK, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003; 41: 2185-92.
10. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415: 219-26.
11. Markides V, Schilling RJ. Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart 2003; 89: 939-43.
12. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769-77.
13. Toft AD, Boon NA. Thyroid disease and the heart. Heart 2000; 84: 455-60.
14. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904-14.
15. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
16. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145: 1386-8.
17. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid 1998; 8: 803-13.
18. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-34.
19. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997; 26: 189-218.
20. Marqusee E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27: 37-49.
21. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-52.
22. von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, et al. Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 1989; 63: 930-3.
23. Osman F, Daykin, Sheppard M, Franklyn J, Gammage M. Cardiac rhythm abnormalities in tyrotoxicosis - the explanation for excess vascular mortality (Abstract). J Endocrinol 2000; 164: P321.
24. Nakazawa HK, Sakurai K, Hamada N, Momotani N, Ito K. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 1982; 72: 903-6.
25. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid 2002; 12: 489-93.